Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?

OBJECTIVE: To evaluate whether the combination of immune checkpoint inhibitor (ICI) with chemotherapy is more effective than ICI alone in the treatment of recurrent, locoregionally advanced, unresectable nasopharyngeal carcinoma (RAU-NPC), which has progressed after second line chemotherapy. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xin, Niu, XiaoShuang, Liu, PeiYao, Ou, Dan, Zhu, Yi, Wang, XiaoShen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589033/
https://www.ncbi.nlm.nih.gov/pubmed/34777379
http://dx.doi.org/10.3389/fimmu.2021.762663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589033/
https://www.ncbi.nlm.nih.gov/pubmed/34777379
http://dx.doi.org/10.3389/fimmu.2021.762663

Ejemplares similares